+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Labor and delivery, also known as childbirth, is the process where the body moves from pregnancy to the birth of a baby. This period can involve different stages, such as cervical ripening, when the cervix softens and opens, and the active phase of l...

Search Bar & Filters

Found 56 Actively Recruiting clinical trials

S

Actively Recruiting

Healthy Volunteer

This clinical trial focuses on pregnant women with a breech presentation who are scheduled for an external cephalic version ECV, a procedure to turn the baby to a head-down position before birth. The study aims to determine if watching an informative video before the planned ECV can reduce maternal anxiety and improve the chances of a successful version. The trial is randomized and sponsored by Meir Medical Center. Participants are divided into two groups one group watches an informative video that explains the ECV process in detail, while the other group does not watch any video before the procedure. Sonographic data such as amniotic fluid index, fetal weight estimates, placenta location, and fetal position angles are collected in the Emergency Room. Anxiety levels are measured using the State-Trait Anxiety Inventory both before and an hour after the ECV, regardless of success. Women in the study will undergo the ECV procedure with clinical monitoring and data collection before and after the intervention. Researchers will assess the primary outcome of higher success rates of the ECV over four years and a secondary outcome measuring the impact of the video on maternal anxiety levels. Participation involves scheduled assessments and monitoring during the procedure, with follow-up for anxiety evaluation and success rates.

Age: 18Years - 45YearsFEMALEPhase Not Applicable
1 location
C

Actively Recruiting

Healthy Volunteer

Researchers are evaluating the pain relief effects and obstetric outcomes of tramadol, paracetamol, and placebo in first-time pregnant women during active labor. This randomized, double-blind, placebo-controlled trial aims to compare how these treatments affect the duration of active labor and other important birth-related factors. The study focuses on nulliparous women and examines both maternal and newborn safety during labor and delivery. Participants receive a single intravenous dose of either tramadol 100 mg, paracetamol 1 g, or a saline placebo at the start of active labor, defined as cervical dilation of at least 4 cm with regular contractions. The study is carefully designed to keep patients and care providers unaware of the assigned treatment to ensure unbiased results. The treatments are administered by trained medical personnel following strict protocols. During the study, researchers collect data on labor duration, delivery type, use of oxytocin, and any side effects experienced by the mother or newborn. Pain levels are also measured before and after treatment. Safety monitoring continues up to 48 hours after birth. The trial includes regular assessments of labor progress and newborn health, with a total participation period covering labor through immediate postpartum. The study is funded and overseen by Universidad Nacional Autnoma de Honduras and conducted at Hospital Escuela in Tegucigalpa.

Age: 15Years - 45YearsFEMALEPhase 4
2 locations
S

Actively Recruiting

Researchers are evaluating the clinical effectiveness of a single intravenous dose of medication to prevent labor arrest and cesarean delivery in first-time mothers experiencing labor dystocia. The focus is on primiparous women with viable single pregnancies who are in the active phase of labor, aiming to improve labor outcomes. This phase 2 and 3 interventional trial is sponsored by The University of Texas Health Science Center, Houston. Participants receive either an experimental treatment of 50 mg IV Diphenhydramine within one hour of a cervical exam diagnosing prolonged active labor or usual care. Usual care includes cervical exams every two hours, use of an intrauterine pressure catheter, adjustment of Pitocin if contractions are insufficient, maternal repositioning, and adjunct devices like a peanut ball. The study compares these two approaches in a randomized design without masking. During the study, researchers monitor cervical dilation up to 4 and 6 hours after treatment start to assess complete dilation. They also track vaginal delivery rates after protracted labor, postpartum complications up to six weeks, and any adverse events in newborns up to six weeks after birth. Participant involvement includes regular cervical exams, labor monitoring, and follow-up for maternal and neonatal outcomes lasting through postpartum hospitalization and six weeks thereafter.

Age: 18Years +FEMALEPhase 2Phase 3
1 location
E

Actively Recruiting

Researchers are examining how uterine contractions, called endometrial peristalsis, affect live birth rates in women undergoing frozen embryo transfer FET using modified natural cycle protocols. These contractions play important roles in fertility by helping sperm and embryo movement and implantation, but abnormal patterns might reduce success. While previous studies mostly looked at fresh embryo transfers or pathological cases, this study focuses on understanding uterine contractions during FET cycles to improve pregnancy outcomes. Participants will follow a modified natural cycle where ovulation is triggered by an injection of human chorionic gonadotropin hCG when the dominant follicle reaches at least 16 mm. Vaginal progesterone will be given starting two days after hCG injection and continued until the pregnancy test day, with extended support up to 10 weeks if pregnancy occurs. Endometrial peristalsis and hormone levels will be measured at three key times early in the menstrual cycle, on the day of hCG trigger before progesterone treatment, and immediately before embryo transfer. During the study, participants will undergo ultrasound and blood tests to assess uterine contractions and hormone levels at specific cycle points. The main outcome measured is the link between uterine contraction frequency and live birth rates. Secondary outcomes include pregnancy rates, direction of contractions, implantation rates, pregnancy complications, and birth outcomes. Participants will be followed through pregnancy to monitor these outcomes, with the total study duration spanning from early cycle assessment to delivery and postpartum evaluations.

Age: 18Years - 42YearsFEMALE
2 locations
I

Actively Recruiting

Researchers are evaluating the BETTER intervention compared to standard obstetrical care to see if it can reduce maternal anemia and other negative pregnancy outcomes. This study focuses on pregnant patients receiving care at two clinics and aims to improve understanding of how addressing social needs through technology and education can affect maternal and child health. It is a pragmatic randomized control trial involving 550 participants. The BETTER intervention involves one motivational interviewing session soon after randomization, encouraging patients to address social needs such as housing, food, and transportation. After that, patients receive bi-weekly text messages with links to resources including a patient portal, a local support organization, and a nationwide resource website. The control group receives standard care without motivational interviewing or text messages. Participants will provide baseline information during a prenatal appointment before 20 weeks of pregnancy and again between 28 and 32 weeks gestation. Data collection continues after delivery, using surveys and electronic health records to assess outcomes like maternal anemia at delivery and other pregnancy complications through about six months postpartum. The study tracks maternal and infant health, including preterm birth, hypertensive disorders, infections, and hospital readmissions.

Age: 18Years +FEMALEPhase Not Applicable
3 locations
S

Actively Recruiting

Healthy Volunteer

Researchers are evaluating the use of calcium carbonate as a medication to help improve contractions during labor. This study focuses on women undergoing labor induction or augmentation, aiming to see if calcium carbonate can lead to stronger contractions, increase vaginal delivery rates, and improve delivery outcomes. The trial is a phase 4 study sponsored by Weill Medical College of Cornell University. Participants will be randomly assigned to one of two groups. The control group will receive standard-dose synthetic oxytocin Pitocin alone for labor induction or augmentation. The experimental group will receive oral calcium carbonate 500 mg every 4 hours alongside the standard-dose synthetic oxytocin infusion. Treatment will continue during hospitalization, which typically lasts about 5 days. During the study, participants will be monitored for adherence to the intervention, labor duration, mode of delivery, postpartum bleeding, treatment-related side effects, and maternal and neonatal health measures such as APGAR scores and cord blood gases. Data on race and ethnicity will also be collected. Safety assessments will continue for up to six weeks after delivery. The total participation duration includes hospitalization of approximately 5 days and follow-up monitoring.

Age: 18Years +FEMALEPhase 4
1 location
P

Actively Recruiting

This research aims to evaluate the effects of energy supplementation with carbohydrate-rich sports gels compared to a low-sugar sports drink in low-risk pregnant women receiving epidural analgesia during labor. The study addresses the increased metabolic demands of labor and investigates whether a carbohydrate solution improves maternal and newborn outcomes. It is a pilot randomized, triple-blind clinical trial involving 142 term pregnant women. Participants will be randomly assigned to receive either a high-carbohydrate sports gel or a low-carbohydrate hydrogel. The first dose is given 60 minutes after epidural analgesia, with subsequent doses every 3 hours during active labor, up to a maximum of four doses. Both interventions are prepared to look and feel identical and are administered orally. Water intake is encouraged throughout labor. During the study, participants will have their labor duration, obstetric and neonatal outcomes monitored. Additional assessments include cardiotocography patterns, maternal and neonatal blood glucose levels, postpartum hemorrhage, vomiting episodes, and maternal satisfaction. The study collects data from epidural administration until delivery and up to 24 hours postpartum, aiming to inform the design of future larger trials.

Age: 18Years +FEMALEPhase Not Applicable
1 location
R

Actively Recruiting

This clinical trial focuses on pregnant women undergoing labor induction to determine if a shorter duration of cervical ripening balloon placement can reduce the time to delivery. The study aims to compare the effects of placing the balloon for 3 hours or less versus the standard 12-hour placement. Researchers also want to see if the shorter placement leads to better pregnancy outcomes, fewer complications, and less maternal discomfort. Participants will be randomly assigned to one of two groups one group will have a double-lumen Cook cervical ripening balloon inserted and removed after approximately 3 hours, while the other group will have the same balloon inserted and removed after about 12 hours. Following balloon removal, labor may continue with amniotomy or Pitocin based on the labor and delivery physicians judgment. Throughout the study, participants will complete a Birth Satisfaction Scale questionnaire. Maternal and neonatal health outcomes will be monitored using hospital records. The primary outcome is the time interval from balloon insertion to delivery, which is tracked up to approximately 48 hours. Secondary outcomes include mode of delivery, time to active labor phases, maternal complications, neonatal outcomes, and hospitalization duration. The study is expected to last until late 2028.

Age: 18Years - 45YearsFEMALEPhase Not Applicable
1 location
S

Actively Recruiting

Healthy Volunteer

Researchers are investigating how combined spinal-epidural CSE analgesia affects blood flow in the uterine and umbilical arteries of women in labor. This study focuses on understanding the possible causes of fetal heart rate changes, such as fetal bradycardia, which can occur in 15-30% of cases after CSE. The aim is to evaluate maternal and fetal blood flow changes before and after CSE, using ultrasound measurements of velocimetric indices. The study involves using ultrasound scans to measure blood flow in the umbilical artery at various times before and after CSE analgesia during labor. Participants include women in active labor with singleton pregnancies, both with and without hypertensive disorders. The blood flow will be monitored at baseline, and then at 5, 10, 20, and 30 minutes after CSE administration. The study is non-randomized and open-label. Participants will undergo ultrasound evaluations to assess blood flow changes and complete pain score questionnaires at set intervals during labor. Researchers will monitor fetal heart rate, uterine contractions, maternal blood pressure, and oxygen levels. Neonatal outcomes like weight and Apgar scores will also be recorded. The study will last up to 24 hours after delivery, with follow-up assessments focused on maternal and fetal circulation and pain control during labor.

Age: 18Years - 50YearsFEMALEPhase Not Applicable
1 location
R

Actively Recruiting

Researchers are evaluating two methods of epidural analgesia for relieving labor pain Programmed Intermittent Epidural Bolus PIEB and Continuous Epidural Infusion CEI, both combined with Patient-Controlled Epidural Analgesia PCEA. This randomized controlled trial aims to compare how well each method controls pain while reducing anesthetic use and preserving maternal motor function. Sixty women in labor at Family Hospital, Da Nang, will be randomly assigned to either the PIEB or CEI group, and outcomes like pain levels, drug consumption, maternal satisfaction, and newborn Apgar scores will be assessed. All participants receive an initial manual epidural dose of 10 mL containing 0.1% Ropivacaine and 2 mcgmL Fentanyl to start analgesia. The PIEB group then receives automated 8 mL boluses every hour, while the CEI group gets a continuous infusion at 8 mL per hour. Both groups can self-administer 5 mL boluses via PCEA with a 10-minute lockout and a maximum of 20 mL per hour. If pain remains high after two PCEA demands, a 5 mL rescue bolus is given by the anesthesia team. Participants will be monitored for pain intensity at multiple time points up to 4 hours after analgesia starts and during labor stages. Researchers will also measure total anesthetic consumption, maternal motor block incidence, maternal satisfaction, and newborn Apgar scores. Monitoring continues until perineal repair is complete, with assessments up to 24 hours after enrollment. The trial is scheduled to start in July 2025 and end in August 2026.

Age: 18Years - 40YearsFEMALEPhase Not Applicable
1 location

1-10 of 56

1

Frequently Asked Questions